• LAST PRICE
    3.7900
  • TODAY'S CHANGE (%)
    Trending Up0.0800 (2.1563%)
  • Bid / Lots
    3.5500/ 1
  • Ask / Lots
    3.8700/ 2
  • Open / Previous Close
    3.6500 / 3.7100
  • Day Range
    Low 3.5500
    High 3.9200
  • 52 Week Range
    Low 3.0250
    High 39.2400
  • Volume
    18,767
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 3.71
TimeVolumeTBIO
09:32 ET7733.66
09:38 ET4853.6701
09:41 ET2003.87
09:43 ET1003.69
09:45 ET10993.9113
10:12 ET1403.795
10:15 ET1003.72
10:21 ET12973.73
10:28 ET14073.651
10:57 ET2003.61
11:36 ET1003.71
11:44 ET1003.6001
11:45 ET1003.6
11:51 ET1503.55
12:03 ET56953.67
12:12 ET5003.67
12:27 ET2003.67
12:34 ET3963.8999
01:51 ET12503.86
03:59 ET21603.79
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTBIO
Telesis Bio Inc
8.3M
-0.1x
---
United StatesOSAPQ
Prosomnus Inc
173.9K
0.0x
---
United StatesAHPIQ
Allied Healthcare Products Inc
400.0
0.0x
---
United StatesSSKN
STRATA Skin Sciences Inc
10.9M
-1.0x
---
United StatesAAXT
Aamaxan Transport Group Inc
1.6K
0.0x
---
United StatesEKSO
Ekso Bionics Holdings Inc
19.2M
-1.1x
---
As of 2024-06-18

Company Information

Telesis Bio Inc. is a provider of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) solutions. The Company provides automated multi-omic and synthetic biology solutions focused on providing applications to enable researchers to rapidly and reproducibly build or write high-quality synthetic DNA and messenger Ribonucleic Acid (mRNA) and short oligonucleotides that are ready to use in many downstream synthetic biology enabled markets. Its BioXp system consolidates, automates, and optimizes the entire synthesis, cloning and amplification workflow. Its on-market and its planned solutions include BioXp 3250 system, BioXp 9600 system, BioXp portal, BioXp De Novo kits, BioXp Select kits, BioXp Next Generation Sequencing kits, Benchtop reagents and Custom Gibson Short Oligo Ligation Assembly (SOLA) enzymatic DNA synthesis (EDS) solutions. BioXp Select kits offer customers the ability to use non-Telesis Bio DNA while using the BioXp system to perform synthetic biology workflow applications.

Contact Information

Headquarters
10431 Wateridge Circle, Suite 150SAN DIEGO, CA, United States 92121
Phone
858-228-4115
Fax
302-636-5454

Executives

Non-Executive Independent Chairman of the Board
Franklin Witney
President, Chief Executive Officer, Director
Eric Esser
Chief Financial Officer
William Kullback
Chief Technology Officer
Daniel Gibson
Chief Legal Officer
Robert Cutler

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$6.2M
Revenue (TTM)
$24.6M
Shares Outstanding
1.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-28.31
Book Value
$17.68
P/E Ratio
-0.1x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-178.98%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.